Sonendo, Inc. (SONX): Price and Financial Metrics

Sonendo, Inc. (SONX): $1.77

0.08 (+4.73%)

POWR Rating

Component Grades













SONX Stock Price Chart Interactive Chart >

Price chart for SONX

SONX Price/Volume Stats

Current price $1.77 52-week high $12.24
Prev. close $1.69 52-week low $1.66
Day low $1.66 Volume 20,915
Day high $1.77 Avg. volume 133,520
50-day MA $2.44 Dividend yield N/A
200-day MA $0.00 Market Cap 46.78M

Sonendo, Inc. (SONX) Company Bio

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software that integrates digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

SONX Latest News Stream

Event/Time News Detail
Loading, please wait...

SONX Latest Social Stream

Loading social stream, please wait...

View Full SONX Social Stream

Latest SONX News From Around the Web

Below are the latest news stories about Sonendo Inc that investors may wish to consider to help them evaluate SONX as an investment opportunity.

What Type Of Shareholders Own The Most Number of Sonendo, Inc. (NYSE:SONX) Shares?

If you want to know who really controls Sonendo, Inc. ( NYSE:SONX ), then you'll have to look at the makeup of its...

Yahoo | February 3, 2022

Sonendo hot streak continues for a third day as shares up 11%

Sonendo shares are up today continuing an upward trend that began on Monday.

Seeking Alpha | January 12, 2022

Sonendo estimates prelim Q4 revenue

Sonendo (SONX) expects to report revenue in the range of $9.7 to $9.9M for Q4; product revenue is expected to be in the range of $7.5 to $7.7M and software revenue is seen at

Seeking Alpha | January 10, 2022

Sonendo, Inc. Announces Preliminary Revenue Results for the Fourth Quarter and Full-Year 2021

LAGUNA HILLS, Calif., January 10, 2022--Sonendo, Inc. ("Sonendo") (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced certain unaudited preliminary revenue results for the fourth quarter and full-year ended December 31, 2021.

Yahoo | January 10, 2022

Reviewing BIOLASE (NASDAQ:BIOL) and Sonendo (NYSE:SONX)

BIOLASE (NASDAQ:BIOL) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends. Insider & Institutional Ownership 11.7% of BIOLASE shares are owned by institutional investors. 2.8% of BIOLASE shares []

Transcript Daily | December 20, 2021

Read More 'SONX' Stories Here

SONX Price Returns

1-mo -27.76%
3-mo -42.53%
6-mo -68.56%
1-year N/A
3-year N/A
5-year N/A
YTD -69.27%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4595 seconds.